Aura Biosciences, Inc.AURANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-3.08%
↓ 140% below average
Average (22q)
7.66%
Historical baseline
Range
High:58.47%
Low:-46.37%
Volatility
1369.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -3.08% |
| Q2 2025 | -1.97% |
| Q1 2025 | 4.52% |
| Q4 2024 | 31.10% |
| Q3 2024 | 0.93% |
| Q2 2024 | -1.01% |
| Q1 2024 | -15.92% |
| Q4 2023 | 31.45% |
| Q3 2023 | 2.04% |
| Q2 2023 | 4.96% |
| Q1 2023 | 9.47% |
| Q4 2022 | 16.52% |
| Q3 2022 | 18.75% |
| Q2 2022 | 14.91% |
| Q1 2022 | 3.72% |
| Q4 2021 | 25.36% |
| Q3 2021 | -4.03% |
| Q2 2021 | 58.47% |
| Q1 2021 | 18.12% |
| Q4 2020 | 24.32% |
| Q3 2020 | -46.37% |
| Q2 2020 | -16.12% |
| Q1 2020 | 0.00% |